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Abstract. The cytoplasmic domains of integrins pro- 
vide attachment of these extracellular matrix receptors 
to the cytoskeleton and play a critical role in integrin- 
mediated signal transduction. In this report we describe 
the identification, expression, localization, and initial 
functional characterization of a novel form of 131 inte- 
grin, termed 131D. This isoform contains a unique alter- 
natively spliced cytoplasmic domain of 50 amino acids, 
with the last 24 amino acids encoded by an additional 
exon. Of these 24 amino acids, 11 are conserved when 
compared to the 131A isoform, but 13 are unique (Zhid- 
kova, N. I., A. M. Belkin, and R. Mayne. 1995. Bio- 
chem. Biophys. Res. Commun. 214:279-285; van der 
Flier, A., I. Kuikman, C. Baudoin, R. van der Neuf, and 
A. Sonnenberg. 1995. FEBS Lett. 369:340-344). Using 
an anti-peptide antibody against the 131D integrin sub- 
unit, we demonstrated that the ~ID isoform is synthe- 
sized only in skeletal and cardiac muscles, while very 
low amounts of 131A were detected by immunoblot in 
striated muscles. Whereas ~IA could not be detected in 
adult skeletal muscle fibers and cardiomyocytes by im- 
munofluorescence, IMD was localized to the sarco- 
lemma of both cell types. In skeletal muscle, 131D was 
concentrated in costameres, myotendinous, and neuro- 
muscular junctions. In cardiac muscle this 131 isoform 
was found in costameres and intercalated discs. 131D 
was associated with oL7A and ot7B in adult skeletal mus- 
cle. In cardiomyocytes of adult heart, et7B was the ma- 
jor partner for the B1D isoform. [31D could not be de- 
tected in proliferating C2C12 myoblasts, but it 
appeared immediately after myoblast fusion and its 
amount continued to rise during myotube growth and 
maturation. In contrast, expression of the [31A isoform 
was downregulated during myodifferentiation in cul- 
ture and it was completely displaced by 131D in mature 
differentiated myotubes. 
We also analyzed some functional properties of the 
[MD integrin subunit. Expression of human 131D in 
CHO cells led to its localization at focal adhesions. 
Clustering of this integrin isoform on the cell surface 
stimulated tyrosine phosphorylation of pp125  FAK (focal 
adhesion kinase) and caused transient activation of mi- 
togen-activated protein (MAP) kinases. These data in- 
dicate that 131D and 131A integrin isoforms are func- 
tionally similar with regard to integrin-mediated 
signaling. 
I 
NTEGRINS are  a  large  family  of transmembrane  het- 
erodimeric receptors  mediating  association  between 
the extracellular matrix (ECM) 1 and cytoskeletal ele- 
ments (Hynes, 1992; Schwartz,  1992; Juliano and Haskill, 
1993; Clark and Brugge, 1995). Integrins play a crucial role 
in cell adhesion including  cell-matrix and intercellular in- 
teractions and therefore are involved in various biological 
phenomena,  including  cell migration,  differentiation,  tis- 
sue repair  and  remodeling, programmed  cell  death,  etc. 
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1. Abbreviations used in this paper.  ECM, extraceUular matrix; MAP, mi- 
togen-activated protein; MBP, myelin basic protein; pp125  FAK, focal adhe- 
sion kinase; RT-PCR, reverse transcription polymerase chain reaction. 
Both oc and [3 subunits are composed of large extracellular 
and short intracellular  domains with the exception of 134 
integrin subunit that possesses an extremely long cytoplas- 
mic  tail.  Experiments  with  chimeric  integrins  demon- 
strated that 13 subunits are necessary and sufficient for tar- 
geting  integrins  to  sites  of  cell-matrix  adhesion  (focal 
adhesions,  focal contacts) in  a  ligand-independent  man- 
ner, while et subunits mostly determine the specificity of 
the ligand binding (Hayashi et al., 1992; LaFlamme et al., 
1992; Ylanne et al., 1993). More than 20 different integrin 
heterodimeric receptors have been described, whereas 8 
integrin 13 subunits and 15 et subunits have been identified 
so far. Among different 13 subunits, the 131 integrin subunit 
is usually the most abundant integrin expressed by adhe- 
sion-dependent cell types (Hynes, 1992). Beta 1 integrin 
associates with at least 10 ct subunits to form distinct inte- 
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lar matrix molecules as well as some cell adhesion mole- 
cules (Hynes, 1992). 
In contrast to the a  subunit cytoplasmic domains, which 
are quite divergent, most B subunits, particularly B1 and 
B3 subunits, share significant homology within their cyto- 
plasmic tails (Tamkun et al., 1986; Argraves et al., 1987; 
Fitzgerald et al., 1987). Cytoplasmic domains of several in- 
tegrin B subunits, including B1, B3, B5, and 136 associate 
with the actin cytoskeleton and are required for the re- 
cruitment of integrins to focal adhesions of cultured cells 
(Sastry and Horwitz, 1993; Hemler et al., 1994). Results of 
in vitro experiments showed that at least two major actin- 
associated proteins present at focal adhesions, talin and 
et-actinin, are capable of interacting directly with B1 inte- 
grin intracellular domain peptides  (Horwitz et al., 1986; 
Tapley et al., 1989; Otey et al., 1990, 1993). Integrin-medi- 
ated cell-matrix interaction during the adhesion process 
induces tyrosine phosphorylation of pp125 FAK and paxillin 
(Guan et al., 1991; Kornberg et al., 1991, 1992; Burridge et 
al., 1992; Guan and Shalloway, 1992; Schaller et al., 1992). 
Clustering of integrins in the plasma membrane with ex- 
tracellular matrix ligands or anti-integrin antibodies trig- 
gers association of some cytoskeletal proteins, including 
talin, vinculin, ot-actinin, tensin, paxillin, and zyxin with in- 
tegrins and leads to nucleation of assembly of actin fila- 
ment bundles at sites of cell-matrix adhesion (Lewis and 
Schwartz, 1995; Miyamoto et al.,  1995). Concomitantly, a 
number of signaling molecules like pp125 FAK, PKC~/, PI- 
3K, and G protein 7 subunit accumulate at focal adhesions 
after integrin engagement and activate a variety of signal- 
ing pathways within the cell  (Clark  and Brugge,  1995). 
Mutants of the B1 integrin cytoplasmic domain are unable 
to  localize  to  focal  adhesion  sites  (Marcantonio  and 
Hynes, 1990; Reszka et al., 1992; Akiyama et al.,  1994). 
The cytoplasmic domain mutants as well as autonomously 
expressed cytoplasmic domain of B1 subunit were shown 
to have a  dominant-negative effect on cell adhesion and 
inhibit outside-in signal transduction of integrins (LaFlamme 
et al., 1994; Lukashev et al., 1994; Smilenov et al., 1994). 
Growing data on 133 integrin subunit cytoplasmic domain 
mutants also indicate a role for both the entire cytoplasmic 
domain and some particular amino acid motifs within it for 
inside-out integrin signaling and regulation of the affinity 
state and ligand-binding properties of the receptor (Chen 
et al., 1994; O'Toole et al., 1994, 1995). 
Recently, two novel isoforms of the [31 integrin subunit 
were described with altered cytoplasmic domains. One of 
them, B1B, is an isoform in which the 26-membrane-prox- 
imal amino acids of the cytoplasmic domain, encoded by 
exon 6 of the B1 integrin gene, are retained and then fol- 
lowed by 12 amino acids derived from the intron sequence 
located adjacent to exon 6 (Altruda et al., 1990). This is a 
rather minor isoform and is coexpressed with B1A in some 
tissues and cells (Balzac et al.,  1993).  Upon transfection 
into cultured cells, B1B serves as a dominant negative inte- 
grin variant, inhibiting cell adhesion and motility appar- 
ently due to its inability to interact with the actin cytoskel- 
eton (Balzac et al., 1993, 1994). Based on this evidence, it 
was suggested that the B1B isoform may function as a "de- 
adhesion" integrin receptor during embryogenesis and in 
some physiological situations in adult tissues (Balzac et al., 
1994).  A  similar isoform of the cytoplasmic domain was 
also  described  earlier  for  the  B3  integrin  subunit  (van 
Kuppevelt et al., 1989). Another B1 integrin isoform with 
an  alternatively  spliced  cytoplasmic domain,  B1C,  was 
identified in  megakaryocytes, platelets  and  some  other 
blood cells (Languino and Ruoslahti, 1992). Its cytoplas- 
mic domain consists of 26 amino acids encoded by exon 6 
and 48 novel amino acids derived from an additional exon 
of the B1 integrin gene. Upon transient transfection into 
mouse 10T1/2 fibroblasts, B1C integrin isoform does not 
localize to focal adhesions and at moderate concentrations 
has no effect on actin stress  fibers and focal adhesions. 
However, B1C expression markedly inhibits DNA synthe- 
sis and causes growth arrest at the late G1 phase of the cell 
cycle (Meredith et al., 1995). 
In this report, we describe intracellular localization, ex- 
pression during myodifferentiation,  interaction with et sub- 
units, and some signaling properties of a  B1 integrin iso- 
form,  termed  BID,  which  has  an  alternatively  spliced 
cytoplasmic domain, where the 24 most COOH-terminal 
amino acids are encoded by a novel exon of the B1 integrin 
gene (Zhidkova et al., 1995; van der Flier et al., 1995). This 
fourth variant of B1 integrin appears to be a muscle-spe- 
cific isoform, replacing the common B1A isoform in termi- 
nally differentiated striated muscles. The B1D isoform lo- 
calizes at various adhesive structures of muscle cells which 
were thought to contain BIA and is associated primarily 
with a7 subunit variants. We also show in CHO cells trans- 
fected with  full-length B1D  cDNA  that  the  exogenous 
muscle-specific B1D subunit is localized to focal adhesions 
of nonmuscle cells and that antibody-induced clustering of 
BID integrin causes an increase in tyrosine phosphoryla- 
tion of pp125 FAK and leads to a transient activation of MAP 
kinases. 
Materials and Methods 
Sources of Cells and Tissues 
C2C12 mouse skeletal myoblasts were obtained from American Type Cul- 
ture Collection (ATCC CRL-1772, Rockville, MD) and cultured in Dul- 
becco's modified Eagle's medium with 10% fetal bovine serum. To switch 
cells to  myodifferentiation, fetal  bovine  serum was  replaced  with  3% 
horse serum in the growth medium. Cells were cultured on plastic dishes 
coated with 0.1% gelatin. CHO cells were obtained from ATCC and cul- 
tured in HAM's F12 medium plus 10%  fetal bovine serum. All culture 
media and supplements were  from GIBCO  BRL (Gaithersburg, MD). 
Mouse tissues were  dissected without dissociation into individual cells. 
Mouse and chicken skeletal muscle samples were taken from adult animals. 
Isolation of RNA and First Strand cDNA Synthesis 
Total RNA from C2C12 cells was obtained by the RNAzolTMB method 
(Biotecx  Laboratories,  Inc.,  Houston, TX)  and poly(A)-rich  RNA  se- 
lected by using the polyATract System IV (Promega Corp., Madison, WI) 
or FastTrack mRNA isolation kit  (Invitrogen Corp.,  San Diego, CA). 
Synthesis of first strand cDNAs was based on a kit (Reverse Transcription 
System; Promega Corp.) using 2-5 Ixg of poly(A)-rich RNA in 50 p,l of 
buffer. A  mixture of random primers (10 ~1) was added and the mixture 
incubated at 65°C and rapidly cooled on ice (1 min). To the RNA/primer 
mixture, 5 p~l of 100 mM methylmercuric hydroxide (Alpha/Johnson Mat- 
they, Ward Hill, MA) was added with incubation for 10 rain at room tem- 
perature followed by 5 p,l of 700 mM 13-mercaptoethanol and incubation 
for 5 rain at room temperature. For first strand cDNA synthesis, avian my- 
eloblastosis virus reverse transcriptase (Promega Corp.)  was employed 
with incubation at 45°C for 45 rain followed by 55°C for 15 rain. The cDNAs 
were precipitated with ethanol and resuspended in 50 txl of water. 
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Synthesized cDNAs were used as a template in the amplification by PCR 
in a  Programmable Thermal Controller (MJ Research Inc., Watertown, 
MA). In order to analyze the cytoplasmic domain of mouse 131 integrin, 
PCR  was  performed  with  primers  NZ1  (5'-2197TrGTGGAGACTC - 
CAGACTGTCCTACT2222-3 ') and PE6 (5'-25°cTCAIq"ITCCCTCATA  - 
CTrCGGATT2477-3'), designed from Argraves et al., 1987; Holers et al., 
1989; using PCR buffers and Taq 1 polymerase (Perkin Elmer, Norwalk, 
CT). The cycle parameters were: denaturation at 94°C for 2 rain, anneal- 
ing at 58°C for 1.5 min, extension at 72°C for 3 rain for 33 cycles with 5 min 
final elongation at 75°C. 
DNA Sequencing 
All sequencing was performed on both strands with Sequcnase  TM version 
2.0 DNA sequencing kit. (U.S. Biochem. Corp., Cleveland, OH). All plas- 
mid templates for sequencing were isolated using the Wizard  TM miniprep 
DNA purification system (Promega Corp.). 
Antibodies 
Rabbit polyclonal anti-peptide antibody against the last 12 amino acids 
(CITVVNPKYEGK) of [MA integrin, which is isoform-specific  and does 
not crossreact with either 131D or other known 131 subunit variants, was 
described and characterized earlier  (Balzac et  al.,  1993,  1994).  Rabbit 
polyclonal antibodies against synthetic peptides derived from the COOH- 
terminal sequences of ctl, ct2, u3, ~4, c~5, and aV integrin subunits were 
generated as described previously (Defilippi et al., 1992). These anti-pep- 
tide antibodies were purified by affinity chromatography on the relevant 
peptides coupled to Scpharose resin. They showed a broad cross-species 
reactivity. Antibodies to the COOH-terminal sequences of a7A and cOB 
were a  kind gift from Dr. Ginetta Collo (Glaxo, Geneva, Switzerland). 
7F9 monoclonal antibody against vinculin was  described earlier  (Gin- 
khova et al., 1990). Anti-phosphotyrosine  mAb PY20 was purchased from 
Transduction  Laboratories  (Lexington, KY).  Anti-MAP kinase  rabbit 
polyclonal antibodies sc-93  and sc-94 were from Santa Cruz Biotechnol- 
ogy (Santa Cruz, CA). Rabbit polyclonal antibody N681  against human 
platelet talin was characterized earlier (Fath et al., 1989). Rat mAb M1.2 
against an extracellular epitope of mouse 131 integrin was a kind gift of Dr. 
B.  Chen  (University of Western  Ontario,  London,  Ontario,  Canada). 
mAb TS2/16  against human integrin 131  subunit was a  gift from Dr. F. 
Sanchez-Madrid (Hospital de la Princesa, Madrid, Spain). Rabbit antise- 
rum 5158  against COOH-terminal portion of pp125  FAz was kindly pro- 
vided by Dr. L  Romer (University of North Carolina, Chapel Hill). 
Generation of Antibody against fllD Integrin Subunit 
Three integrin cytoplasmic domain peptides were synthesized at the Pep- 
tide Synthesis Facility of the Department of Chemistry, University of 
North Carolina, Chapel Hill. A 48-mer CKLLMIIHDRREFAKFEKEK- 
MNAKWDTGENPIYKSAVITVVNPKYEGK corresponded to the amino 
acid sequence of integrin 131A whole cytoplasmic domain. A second pep- 
tide was a 51-met CKLLMIIHDRREFAKFEKEKMNAKWDTQENPI- 
YKSPINNFKNPNYGRKAGL, which represented the entire cytoplasmic 
domain sequence of the novel 131D integrin subunit. The third peptide was 
a 17-met CPINNFKNPNYGRKAGL, which contained an amino acid se- 
quence present only in the 131D isoform, and not in 131A isoform. An NH  2- 
terminal cysteine, was added to all peptides to orient peptide coupling to 
either carrier protein keyhole limpet hemocyanin or to the activated resin 
thiopropyl Sepharose 6B  (Pharmacia-Biotech., Uppsala, Sweden). The 
51-mer corresponding to the whole cytoplasmic sequence of 131D was con- 
jugated  to  Imject  TM  maleimide-activated keyhole  limpet  hemocyanin 
(Pierce, Rockford, IL) at a ratio of ~50-100 mol of peptide to 1 tool of the 
protein. Rabbits were immunized subcutaneously with i mg of this conju- 
gate in complete Freund's adjuvant  (GIBCO  BRL)  and boosted 5  wk 
later  with  0.5  mg  of this  conjugate  in  incomplete Freund's  adjuvant 
(GIBCO BRL). Boosts were repeated every 4 wk with 0.5 mg of the con- 
jugate. Serum was collected which gave some positive reaction in immu- 
noblotting of extracts of muscle tissues. Both a 48-mer representing the 
whole cytoplasmic domain of 131A subunit and a 17-mer, containing the 
new amino acid sequence specific for 131D subunit, were coupled to thio- 
propyl Sepharose 6B according to the manufacturer's instructions. Pooled 
antiserum was preadsorbed first with immobilized 131A integrin cytoplas- 
mic domain peptide and the unbound material was loaded onto a column 
containing immobilized 17-mer, representing the new sequence of 131D in- 
tegrin isoform. The column was extensively washed with 50 mM Tris-HCl, 
1.5 M NaCI, pH 7.5, and bound material was eluted with 200 mM Glycine 
adjusted to pH 2.2 with HCI. The pH of the column eluate was immedi- 
ately readjusted to pH 8.0 with 1 M  "Iris,  and the affinity-purified IgG 
fraction was extensively dialyzed against 0.1 M NaaBO4,  150 mM NaCI, 
pH 8.1, and stored at 4°C in the presence of 2% BSA. 
lmmunoprecipitation, Electrophoresis, and 
lmmunoblotting  of iliA and fllD Integrins 
For immunoprecipitation, various adult mouse tissues were homogenized 
and boiled in 1% SDS, tissue extracts were spun down and supernatants 
were diluted with 1% Triton X-100 in 50 mM Tris-HCl, 150 mM NaCl, pH 
7.5, to give a final SDS concentration of 0.1%. Protein concentration was 
determined in tissue extracts using Micro BCA Protein Assay Reagent Kit 
(Pierce) and samples containing Img of total protein were taken for sub- 
sequent immunoprecipitation with antibodies. Ceil and tissue lysates were 
subjected to immunoprecipitation with either anti-131A or anti-131D inte- 
grin antibodies (~5-10 p,g of affinity-purified anti-131A or anti-131D IgG 
were used per one sample), followed by protein A-Sepharose beads. Both 
incubations were done  at  4°C on the rotator.  Beads were extensively 
washed with 1% Triton X-100 in 50 mM Tris-HC1,  150 mM NaCl, pH 7.5, 
and  immunoprecipitates  were  boiled  in  electrophoresis  SDS  sample 
buffer. For electrophoresis, 10% polyacrylamide gels, containing 0.13% 
hisacrylamide, were used (Laemmli, 1970). Proteins were transferred onto 
Immobilon Membranes (Millipore, Bedford, MA) as described by Towbin 
et al. (1979). Blots were blocked with 2% BSA, 2% cold water fish gelatin, 
0.1% Tween 20 in TBS (50 mM Tris-HCl, 150 mM NaCI, pH 7.5) for 1 h. 
Then blots were incubated with 0.5 }xg/ml of anti-131A or anti-131D IgG. 
Goat anti-rabbit affinity-purified IgG, conjugated with peroxidase (Jack- 
son Immunoresearch, West Grove, PA), diluted 1:10,000, was used as the 
secondary antibody. Blots were extensively washed with TBS plus 0.1% 
Tween 20, then with TBS and finally developed using ECL reagents (Am- 
ersham, Arlington Heights, IL). 
To study the expression patterns of 131D and 131A during myodifferentia- 
tion in culture, C2C12 cells, taken on day 1 to day 9 after plating, were lysed 
in 1% SDS. 0.5 mg of total cellular protein was taken for immunoprecipita- 
tion using the method described above. To separate myotubes from the re- 
maining myoblasts in culture for the analysis of 131D and 131A content in 
both  cell  populations,  C2C12  mixed  myoblast/myotube  cultures  were 
treated first with 0.01%  trypsin, 0.004%  EDTA for 15 min. Under these 
conditions myotubes slowly detached from the substrate, whereas 0.05% 
trypsin and 0.02%  EDTA was needed to deadhere remaining myoblasts. 
Constructs and Transfections 
The  eDNA  for the  131D isoform was prepared  from the human  131B 
eDNA in the pECE vector (Balzac et al., 1994). The Hind III site in the 
polylinker of the vector was removed and the sequence encoding the cyto- 
plasmic region of 131B between the two Hind III sites (positions 2250 and 
2742, respectively, starting from the ATG) was then replaced with the new 
sequence specific for the 131D variant. The DNA fragment corresponding 
to the 131D specific sequence was prepared by PCR amplification using 
mouse eDNA as a template. The PCR primers included Hind III sites for 
cloning into the vector. 
Stable transfectants of CHO cells expressing the human integrin 131A 
or 131D were obtained as described previously (Balzac et al., 1993, 1994). 
Briefly, a 3.5-kb EcoRI fragment of the 131D integrin containing the entire 
coding sequence was inserted into the EcoRI-cloning site of the SV40- 
based expression vector pECE (Ellis et al., 1986). The full-length cDNA 
for the human [31A integrin cloned in the pECE vector was a kind gift of 
Dr. Filippo Giancotti (Giancotti and Ruoslahti, 1990).  CHO cells were 
cotransfected with 20  p,g of the plasmid containing either 131A or 131D 
eDNA and 2 mg of pSV2-neo (Southern and Berg, 1982), and neomycin- 
resistant clones were selected in Ham's F12 medium with 10% FCS and 
800 ixg/ml of G418  (GIBCO BRL). Cells expressing the transfected pro- 
tein were selected by plating on a dish coated with 50 ~g/ml of mAb BV7 
reacting with an extracellular epitope of the human 131 integrin (Martin- 
Padura et al., 1994). Adherent cells were grown and subjected to repeated 
cycles of selection on the antibody until the appropriate expression level 
was achieved. Flow cytometry analysis of the transfectants was performed 
as described earlier (Balzac et al., 1994). 
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~ I D-  Transf  ectants 
CHO transfectants  were kept in serum-free  Ham's F12 medium for ~3 h 
before their detachment.  Confluent  cells were de-adhered from culture 
flasks with 0.05% trypsin, 0.53 mM EDTA and turkey egg trypsin inhibi- 
tor (Sigma) was immediately  added to the cell suspension  up to a final 
concentration  of 0.5 mg/ml. The suspended  cells were washed twice with 
Ham's F12 medium plus 2% BSA and cell suspensions were incubated for 
1 h  at 37°C on the rotator. For plating  experiments,  T25 tissue  culture 
flasks were precoated with mAb TS2/16 against human  IM integrin,  at a 
concentration  of 10 p.g/ml, as described earlier (Balzac et al., 1994). 
2262..  t  tata~aaacto~aaa~at  cctac~ggt  cccgaeat  cat  ccca  ~ID 
718..  V  E  T  P  D  C  P  T  G  P  D  I  I  P 
2262..  t  Eataaaaacncca~actatcctac  ~  qgtccegacatca~ccca  ~IA 
B  "7~18..  V  E  T  P  D  C P  T  G  P  D  Z  I  P 
2307..  attgtagcaggcgtggttgc~ggaattgttcttattggcctt  ~ID 
732..  I  V  A  G  V  V  A  G  ~  V  L  7  G  T, 
2307..  attgtagcaggcgtggt  tgc  tggaa~gt  t  et  tart  ggcc~t  ~IA 
732..  I  V  A  G  V  V  A  G  I  V  L  I  G  T, 
2348..  gccttgctgctgatt  tggaaacttttaatgataat  tcatgac  ~ID 
746..  ~  K  L  L  M  I  I  H  D 
2348..  gcc  ~tgc~gc~gaut  tggaaact  t  t  taatgauaa~catgac  ~IA 
746..  A  L  L  L  Z  W  K  L  L  M  I  I  H  D 
2389..  agaagggaat~tgctaaatttgaaaaggagabaatgaatgcc  ~ID 
760..  R  R  E  F  A  K  P  E  K  E  K  M  N  A 
2389..  agaagggaa~ttgctaaatttgaaaaggagaaaatgaatgcc  ~IA 
760..  R  R  E  F  A  K  F  E  K  E  K  M  N  A 
2430..  aagtgggacacccaagaaaa~ccgatttacaagagtcctatt  ~ID 
774..  R  W  D  T  Q  E  N  P  I  Y  K  S  P  I 
2430..  aagtgggacacc  ~IA 
774..  K  W  D  T 
2471..  aataa~tcaagaa~ccaaac~a~ggacg~aaagctggtc~c  ~ID 
788..  N  N  F  K  N  P  N  Y  G  R  K  A  G  L 
2512..  tgagtttccggtgaaaa~cc~atttacaagagcgccgtgaca  ~lO 
792..  * 
2442  ....  gg~gaaaatcctat~acaagagcgccgtgaca  ~IA 
778  ....  GENPIYKSAVT 
~--PE6 
2553..  actgtggtcaatcc~aaatatuaaaaaaaat~  ~ID 




~IA  ...AKWDT 
~IB  ...AKWDT 
131C ...AKWDT 
~ID  ...AKWDT 
GENPIYKS  AVTq~VNPKY_.EG_.K 
VSYKTSKKQSGL 
SLS  VAQPGVQWCDIS  SLQPLTSRFQQFS  CLS  LPSTWDYRVKILFIRVP 
OENPIYKSPINNFKNPN~GR]~,AGL 
Figure 1.  Identification of the 131D integrin isoform by RT-PCR, sequence of ~ID integrin and its comparison to other IM integrin cy- 
toplasmic domain variants. (A) Agarose gel electrophoresis of the products of an RT-PCR reaction performed with RNA from cultured 
C2C12 cells taken at different stages of myodifferentiation using primers NZ1 and PE6. Lane 1, I day; lane 2, 3 days; lane 3, 9 days; lane 
4, 12 days; lane 5, molecular markers, from top to bottom are: 1 kb; 0.7 kb; 0.5 kb; 0.3 kb; 150 bp; 50 bp. (B) Sequence of mouse 131D iso- 
form and its comparison to 131A. RNA was isolated from differentiated C2C12 cells (day 9, lane 3) and both PCR bands were cloned be- 
fore DNA sequencing. Note that the 131D isoform contains an insert of 81 nucleotides of which 72 nucleotides are in an open reading 
frame. The amino acid sequence of the transmembrane domain of 131D and IMA is underlined. NZ1 and PE6 are antisense oligonucle- 
otides used for PCR amplification. These sequence data are available from GenBank/EMBL/DDBJ under accession number U37029. 
(C) Comparison of the amino acid sequences of the 131  integrin cytoplasmic domain isoforms. Shown are the predicted amino acid se- 
quences of the COOH-terminal part of the cytoplasmic tails of ~IA, IMB, 131C and 131D isoforms as the result of differential splicing 
events. Note that  I~IA and tMD, but not 131B and 131C isoforms, share a significant homology including two conserved NPXY motifs 
(identical amino acids in ~IA and IMD are underlined). 
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CHO transfectants on TS2/16 mAb, plated cells, taken at various time- 
points (15, 30, 60, and 150 rain) and cells kept in suspension, were rinsed 
twice with PBS and lysed with buffer, containing 50 mM Tris-HCl, pH 7.5, 
150 mM NaC1, 1% Triton X-100, 0.5% Na deoxycholate, 0.1% SDS, 1 mM 
Na orthovanadate, 10 ~g/ml leupeptin, and 10 p~g/ml pepstatin, i ml of ly- 
sis buffer was used for each T25 tissue culture flasks. Cell lysates were pre- 
cleared by centrifugation (10,000 rpm, 15 min, 4°C). Protein content in cell 
lysates was determined using Coomassie Protein Assay Reagent (Pierce) 
and 1 mg of total cellular protein was  taken for immunoprecipitation. 
Rabbit antiserum 5158 against pp125 FAK (5 p~l per sample) and protein 
A-Sepharose were used to precipitate pp125 F~ac from cell lysates. The re- 
sulting immunoprecipitates were washed five times with lysis buffer, once 
with PBS and finally boiled in SDS sample buffer for electrophoresis. 
Samples were loaded on 10% gels and blots were probed with PY20 mAb 
(1 txg/ml) followed by goat anti-mouse afffinity-purified IgG, conjugated 
to peroxidase (Jackson) taken at 1:10,000 dilution. 
To study activation of MAP kinases by gel mobility shift assay in re- 
sponse to CHO cell attachment and spreading via either 131A  or 131D inte- 
grins, CHO transfectants were plated on TS2/16 mAb as described above. 
Cells kept in suspension or plated on the antibody-coated surfaces for 30, 
90, or 200 min, were rinsed with PBS and cells lysed with 2% SDS plus 1 
mM Na orthovanadate (200 p,l of lysis buffer per each T25 flask or pellet 
of suspended cells)  and cell lysates were immediately boiled for 5 min. 
Protein content in different samples was equalized and 50 p,g of total cel- 
lular protein was loaded onto each gel lane. Electrophoresis on 15% poly- 
acrylamide gel was used to improve the resolution of MAP kinase bands. 
Polyclonal antibody sc-94, reacting with both MAPK1 and MAPK2 ki- 
nases (1:1,000 dilution) was used in combination  with secondary goat anti- 
rabbit affinity-purified IgG (Jackson, diluted 1:10,000) for visualization of 
MAP kinase bands on the blot. 
To analyze activation of MAP kinases by immune complex kinase ac- 
tivity assay in CHO cells transfected with 131A and 131D integfins, cells 
were kept in suspension or plated on TS2/16 mAb-coated dishes for 15, 30, 
45, or 150 min. Cells were lysed with 1 ml of buffer, containing 150 mM 
NaCI, 1% Nonidet P-40, 0.5% Na-deoxycholate, 50 mM Hepes, pH 7.5, 1 
mM Na orthovanadate, 50 mM NaF, 1 mM p-nitrophenyl phosphate, 20 
nM calyculin  A, 10 p~g/ml aprotinin, 10 p~g/ml leupeptin, and 1 raM phe- 
nylmethylsulfonyl fluoride. Protein content in various samples was equal- 
ized using Coomassie Protein Assay Reagent (Pierce) and 0.5 mg of total 
cellular protein was taken for immunoprecipitation. MAP kinases were 
immunoprecipitated using sc-93 rabbit antibody (1  p.g per sample) fol- 
lowed by protein A-Sepharose.  Immune complexes were washed four 
times with the lysis buffer, twice with 0.25 M Tris-HCl, pH 7.6, and once 
with 0.1 M NaCI, 50 mM Hepes, pH 8.0. The immunoprecipitated MAP 
kinases were incubated with 100 ml of a mixture, containing 1 p.Ci of ['y- 
32p]ATP, 50 p,M ATP, 10 mM MgCI2, 1 mM dithiothreitol, 1 mM benza- 
midine, 0.3 mg/ml myelin basic protein (MBP), and 25 mM Hepes, pH 8.0, 
at 30°C for 20 rain. The reaction was stopped by boiling supernatants in 
SDS sample buffer. 10 p,g of MBP was loaded on a 15% polyacrylamide 
gel. Proteins were fixed, stained with Coomassie Brilliant Blue and the gel 
was dried and exposed to Kodak x-ray Film for visualization of phosphor- 
ylated MBP bands. 
Immunofluorescence 
For immunofluorescent staining of skeletal and cardiac muscle sections, 
5-7 ixm cryosections of mouse or chicken adult muscle tissues were fixed 
for  10 min with ice-cold  acetone.  Cryosections were blocked with 2% 
BSA in PBS and then incubated with 10 p,g/ml of either anti-131A or anti- 
131D IgG. Affinity-purified goat anti-rabbit IgG, coupled with Texas Red 
(Chemicon, Temecula, CA), taken at 1:40 dilution, was used as secondary 
antibody. Localization of 131D and 131A in mouse adult skeletal and car- 
diac muscle tissues was also compared with the distribution of vinculin, vi- 
sualized with 7F9 mAb. In this case, a mixture of donkey anti-rabbit IgG, 
conjugated with Texas Red (Chemicon, 1:40 dilution), and donkey anti- 
mouse IgG, conjugated with fluorescein (Chemicon, 1:40 dilution), was 
used as both secondary antibodies for simultaneous visualization of anti- 
gens.  To  visualize  131D or  131A integrins at  neuromuscular junctions, 
chicken skeletal muscle tissue sections were double stained using fluores- 
cein-conjugated goat anti-rabbit IgG in combination with rhodamine-con- 
jugated a-bungarotoxin (Molecular Probes, Eugene, OR). Adult chicken 
skeletal muscle tissue sections,  containing myotendinous junctions were 
double-stained with anti-131D or anti-131A variant-specific antibodies fol- 
lowed by fluorescein-conjugated goat anti-rabbit IgG (1:40 dilution) and 
7F9  mAb  against vinculin followed  by  rhodamine-conjugated donkey 
anti-mouse IgG (1:40 dilution). 
To study localization of 131D in differentiating C2C12 myocytes by im- 
munofluorescence, C2C12  cells,  growing  on  laminin-coated coverslips, 
were taken at various timepoints of myodifferentiation, fixed with ice-cold 
methanol and stained with 10 p,g/ml of anti-131D antibody, followed by 
goat anti-rabbit IgG, conjugated with Texas Red (1:40 dilution). 
For immunofiuorescent staining of 131A- and  131D-expressing CHO 
transfectants, cells cultured in Ham's F12 medium with 10% FCS,  were 
detached with trypsin and then replated on fibronectin-precoated glass 
coverslips for 3 h. Cells were fixed with 3.7% formaldehyde in PBS for 10 
min and permeabilized with 0.5% Triton X-100 in PBS for 2 min. For dou- 
ble-staining of 131A- and 131D-CHO transfectants, TS2/16 inAb against 
human 131 integrin was used in combination with rabbit polyclonal anti- 
talin antibody. A  mixture of donkey anti-mouse IgG conjugated with 
rhodamine (1:40 dilution) and donkey anti-rabbit IgG coupled with fluo- 
rescein (1:40 dilution), was used for both secondary antibodies. 
Analysis of fllD Association  with a Subunits 
Frozen mouse skeletal and cardiac muscle tissues were triturated in liquid 
nitrogen, extracted and sonicated at 4°C in 0.5% Triton X-100 in 20 mM 
Tris-HCl,  pH 7.4, 150 mM NaCI, I mM CaCl  2, I mM MgC12, 10 p,g/ml leu- 
peptin, 4 p,g/ml pepstatin, and 0.1 TIU/ml aprotinin. After centrifugation 
at 10,000 g for 10 rain, extracts were preincubated with nonimmune rabbit 
IgG, coupled to Sepharose for removing the material that nonspecifically 
binds Sepharose. Integrin complexes were immunoprecipitated by incu- 
bating with the specific antibodies to alpha subunits for 15 h at 4°C with 
gentle agitation, followed by I  h  incubation with protein A-Sepharose 
Figure 2.  I31D integrin subunit is expressed only in skeletal and 
cardiac muscles of adult mouse. Immunoblotting of correspond= 
ing immunoprecipitates (see Materials and Methods for details) 
from  thigh skeletal muscle  (a),  diaphragm skeletal  muscle  (b), 
heart (c), aorta  (d),  placenta  (e),  lung (f),  spleen  (g),  skin  (h), 
liver (i), gut (j), kidney (k), or brain (/) of adult mouse was per- 
formed with anti-peptide isoform-specific antibodies against [31D 
(A) and 131A (B). Positions of molecular weight markers in kilo- 
daltons are indicated to the right of each blot. Arrows show IMD 
bands in A  and IMA bands in B. 
Belkin et al. fllD lntegrin Displaces fllA in Muscle Cells  215 Figure 3.  Localization of 131D and 131A  integrin isoforms in adult skeletal muscle. Transverse cryostat sections of skeletal muscle from 
adult mouse (5-/zm) were double-stained with polyclonal antibody against BID (A) and anti-vinculin mAb 7F9 (B) or polyclonal anti- 
body against [31A (C) and anti-vinculin mAb 7F9 (D). Arrows point to the sarcolemma of skeletal muscle fibers, arrowheads indicate 
nonmuscle 131A integrin-positive cells, not expressing BID integrin isoform. Bar, 50 ixm. 
beads (Pharmacia). After extensive washing, bound material was eluted 
by boiling the beads in SDS sample buffer with or without 13-mercaptoeth- 
anol respectively for immunoblotting with either 131D antibody or rat 
M1.2 mAb against mouse 131 integin subunit. Proteins were run on a 6% 
SDS-polyacrylamide gel, transferred to nitrocellulose and probed with ei- 
ther anti-BID antibody (0.5 i~g/ml) or with 0.2 ixg/ml of the rat mAb M1.2 
to the mouse 131 integrin subunit. Peroxidase-conjugated anti-rabbit IgG 
(Sigma, Italy) or peroxidase-conjugated anti-rat IgG (Boehringer Mann- 
heim Corp., Mannheim, Germany) were used as secondary antibodies. 
Results 
Identification and Amino Acid Sequence of  Mouse fllD 
Integrin Cytoplasmic Domain Isoform 
In preliminary experiments, it was observed that a  poly- 
clonal anti-peptide antibody to the cytoplasmic domain of 
[31 integrin (Marcantonio and Hynes, 1988) failed to give 
immunofluorescent staining  of the  sarcolemma  of adult 
skeletal and cardiac muscles (A. M. Belkin, N. I. Zhidkova 
and V. E. Koteliansky, unpublished observations). How- 
ever, polyclonal or monoclonal antibodies to the extracel- 
lular domain of [31 integrin always gave strong immunoflu- 
orescent staining  of the surface of adult striated muscle 
cells (Bozyczko et al., 1989; Swasdison and Mayne, 1989). 
These observations first suggested the possibility that an 
isoform of the cytoplasmic domain of [31 integrin might 
displace the ubiquitously expressed [31A isoform in muscle 
cells.  To  examine  this  possibility,  reverse  transcription 
polymerase chain reaction (RT-PCR) reactions were per- 
formed  using  RNA  preparations  obtained  from  C2C12 
cells taken at various timepoints of myodifferentiation and 
24-mer antisense oligonucleotides NZ1 and PE6 that span 
the portion of [31 integrin subunit mRNA encoding trans- 
membrane and cytoplasmic domains. At early timepoints 
preceeding cell fusion in myogenic culture, only one band 
most  likely corresponding to  the  [31A isoform was  de- 
tected (Fig. 1 A, lanes 1 and 2). However, after cell fusion 
occurs in C2C12 culture and myotubes grow and differen- 
tiate, a prominent upper band was detected together with 
the original lower band  (Fig.  1 A, lanes 3  and 4).  Each 
band  was  subcloned  into  the  PCR~II  vector and  sub- 
jected  to  nucleotide  sequencing  (Fig.  1  B).  The  results 
showed that the lower band had an identical nucleotide se- 
quence to the published sequence for the mouse B1A iso- 
The Journal of Cell Biology, Volume 132, 1996  216 Figure 4.  Localization of 131D integrin at various adherens-type junctions of adult skeletal muscle. 5-~m longitudinal cryostat sections 
of tibialis anterior skeletal muscle from 8-wk-old chicken were prepared. Sections were double stained with anti-biD antibody (A) and 
a-bungarotoxin (B). Small arrows in A and B depict acetylcholine receptor dusters, colocalized with 131D integrin. (C) 131D integrin is 
localized at skeletal muscle costameres. Micrograph represents a field where the section plane is close to the surface of myofibers. Mus- 
cle-tendon interface was costained with antibodies against 131D integrin (D) and vinculin (E) to show accumulation of 131D integrin at 
myotendinous junctions. Bar, 50 Ixm. 
form (Holers et al., 1989).  However, the upper PCR-gen- 
crated band contained an additional 81-bp insert with an 
open reading frame for 72 bp after the stop codon. The po- 
sition of the 81-bp insert, encoded by a novel exon of the 
131 integrin gene coincided with the boundary between ex- 
ons 6 and 7 of the gene (Lanza et al., 1990) where all the 
diversity of previous 131 integrin cytoplasmic domain iso- 
forms was shown to be generated by differential splicing 
(Altruda et al., 1990; Languino and Ruoslahti, 1992). The 
deduced amino acid sequence differed markedly from the 
previously described 131B and 131C isoforms and this newly 
identified 131 integrin variant was therefore assigned f31D. 
Fig.  1  C  shows  the comparison of 131D integrin with all 
other known cytoplasmic domain isoforms. Notably, the 
COOH-terminal parts  of 131A and  131D cytoplasmic do- 
main variants, unlike the alternatively spliced amino acid 
sequences of 131B and 131C, share 11 amino acids in com- 
mon, including two conserved NPXY motifs at the same 
positions (Fig. 1 C, underlined). The amino acid sequence 
for  mouse  131D was  identical  to  the  recently reported 
chicken  and  human  131D sequences  (Zhidkova  et  al., 
1995). 
The [31D lntegrin Isoform Is the Predominant 
[31 Integrin lsoform Expressed in Skeletal and 
Cardiac Muscles 
Using  an  anti-peptide  antibody specific for the  131D se- 
quence, we examined the expression pattern of this inte- 
grin in various tissues of adult mouse by immunoprecipita- 
tion and subsequent immunoblotting and compared it to 
that of 131A isoform. Significant amount of 131D integrin, 
represented by a broad band with a Mr around 140 kD was 
found in two different types of skeletal muscle (Fig. 2 A, a 
and b). In heart muscle extracts a slightly slower migrating 
band of f31D was detected (Fig. 2 A, c). The 131D isoform 
was not detected in any other tissues analyzed except for a 
very weak reaction in  skin.  This may be explained by a 
trace contamination of this  sample with  skeletal  muscle 
cells. In contrast, the 131A isoform was detected in all the 
Belkin et al. fllD Integrin  Displaces  ~IA in Muscle Cells  217 Figure 5.  Localization  of IMD and [31A integrin isoforms in adult cardiac muscle. (A-C) Serial transverse cryostat sections of mouse 
adult cardiac muscle (5-txm) were stained with antibody against [31D (A), anti-vinculin mAb 7F9 (B), or antibody against 131A (C). Ar- 
rows mark the cardiomyocyte sareolemma, arrowheads indicate nonmuscle ceils, expressing 131A but lacking 131D integrin isoform. (D- 
F) Longitudinal  cryostat sections of mouse adult cardiac muscle (5-/~n) were either double-stained  with antibody against 131D (D) and 
anti-vinculin mAb 7F9 (E) or stained with antibody against 131A (F). Small arrows mark cardiomyocyte costameres, arrowheads point to 
intercalated  discs. Bar, 20 p~m. 
tissue samples analyzed, but with slightly weaker reaction 
in  cardiac  muscle  and  notably fainter bands  in  the  two 
skeletal muscle samples analyzed (Fig. 2 B). These data in- 
dicated that 131D is the predominant 131 integrin variant in 
adult striated muscles. 
Localization of 131D and [31A Integrin Isoforms in 
Adult Skeletal and Cardiac Muscles 
Double immunostaining of transverse sections of skeletal 
muscle with  antibodies  against  the  131D integrin  variant 
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lemma of skeletal muscle fibers (Fig. 3 A, arrows).  Some 
nonmuscle cells, present in the skeletal muscle tissue, were 
positive for vinculin but did not express any 131D (Fig. 3, A 
and B, arrowheads).  In contrast, the 131A integrin isoform 
was  virtually  undetectable  at  the  sarcolemma,  but  was 
clearly visualized in some connective tissue and capillary 
cells of the tissue (Fig. 3, C and D, arrows, arrowheads). 
Detailed analysis of the intracellular localization of the 
131D isoform in skeletal muscle showed that this integrin 
subunit  is  accumulated  at  all  major  adherens-type  junc- 
tions  of skeletal  muscle  fibers  (Fig.  4).  Double-labeling 
with ~x-bungarotoxin revealed the  presence of 131D inte- 
grin at neuromuscular junctions (Fig. 4, A  and B, arrows). 
[31D was also localized at skeletal muscle fiber costameres 
(Fig. 4 C). Finally, a very intense staining of the myotendi- 
nous junction was obtained with anti-131D antibody, show- 
ing that  131D is particularly enriched at these cell-matrix 
junctional  sites (Fig.  4,  D  and  E).  The  131A integrin  iso- 
form was not  identified  at any of these junctional  struc- 
tures (data not presented). 
In cardiac muscle, the 131D integrin isoform was promi- 
nent at the sarcolemma of cardiomyocytes and codistrib- 
uted  with  vinculin  (Fig.  5,  A  and  B, arrows).  Although 
abundantly  expressed in  nonmuscle  ceils present  in  this 
tissue,  the  131A integrin  subunit  was not  detected  at  the 
sarcolemma (Fig. 5 C, arrowheads).  With longitudinal sec- 
tions  of  cardiac  muscle,  we  could  detect  131D integrin 
staining at both costameres and intercalated discs, two ma- 
jor adherens-type junctions  of cardiomyocytes (Fig. 5 D) 
which also contain vinculin (Fig. 5 E). Again, the 131A in- 
tegrin variant was not localized at these two types of junc- 
tional structures in cardiac muscle (Fig. 5 F). 
Association of fllD with a7 Subunit Isoforms In Vivo 
Western  blot analysis with  a  panel of antibodies  specific 
Figure 6. Association  of 131D 
integrin isoform with integrin 
subunits  in  adult  mouse 
skeletal and cardiac muscles. 
Mouse  muscle  tissues  were 
extracted  under  conditions 
favoring association of a and 
13 subunits  and integrin  com- 
plexes  were immunoprecipi- 
tated  with  antibodies  spe- 
cific for ~3, a5, c~V, ~x7A, and 
c~7B integrin  subunits.  After 
electrophoresis  and  elec- 
trotransfer,  co-precipitated 
131 integrin  isoforms were vi- 
sualized  on immunoblots by 
reacting with antibodies  spe- 
cific to the 131D isoform (top) 
or antibody to an extracellu- 
lar  epitope,  common  to  all 
four known  131  integrin  iso- 
forms. Note that 131D was de- 
tected  in  association  only 
with  a7B  subunit  in  heart 
muscle and in skeletal muscle 
131D is associated  with  a7A 
and a7B. 
for ct subunits  indicated  that  c~3, ct5, ctV,  et7A,  and  tx7B 
were the major integrin et subunits expressed in adult skel- 
etal muscle (data not shown). In adult heart muscle a simi- 
lar pattern of c~ subunits was detected except that a7A was 
absent (Fig. 6, bottom), confirming previous report (Collo 
et al., 1993).  To assess which (x subunit was associated with 
131D  integrin,  tissue  extracts  were  immunoprecipitated 
with various antibodies  against ~x subunits  and  immuno- 
precipitates  were  probed  by  immunoblotting  with  anti- 
131D antibody or an anti-B1 mAb reacting with all known 
131 isoforms. As shown in Fig. 6, 131D integrin appeared to 
be associated exclusively with ct7A and a7B subunit vari- 
ants in skeletal muscle, whereas in cardiac muscle a7B was 
the major pairing partner for the 131D. e~3 and tx5 subunits 
which are known to be expressed in the connective tissue 
and blood vessels present in muscle tissues, are associated 
with a different [31 isoform, probably 131A, since there was 
a prominent reaction in immunoblot of anti-~3 and anti-~5 
immunoprecipitates with anti-131 antibody (Fig. 6). Only a 
very minor portion of 131 was found associated with aV in 
adult muscle tissues. 
Expression and Localization of BID Integrin 
during Myodifferentiation 
During  myodifferentiation of mouse  C2CI2 cells  in  cul- 
ture,  131D could not be detected in replicating myoblasts 
(Fig. 7 A, a and b). Immediately after cell fusion occurred, 
a  131D band was detectable (Fig. 7 A, c). Thereafter, the 
amount of 131D continued to increase reaching its highest 
level at day 9 through day 10, when mature differentiated 
myotubes appear in the cell culture (Fig. 7 A, d  and e). In 
contrast, large amounts of 131A isoform were found in pre- 
fusion myoblasts (Fig. 7 B, a and b). A  significant decrease 
in the content of 131A acccompanied subsequent stages of 
myodifferentiation after cell fusion, and only a weak 131A 
band was seen at late timepoints in C2C12 culture (Fig. 7 
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myodifferentiation of C2C12 cells. (A and B) Cells, taken on day 
1 (a), day 3 (b), day 5 (c), day 7 (d), and day 9 (e) after plating, 
were lysed and cell lysates were subjected  to immunoprecipita- 
tion and subsequent immunoblotting with anti-131D (A) or anti- 
131A (B) antibody. (C) Myotubes (b and b') were separated from 
the remaining nonfused myoblasts (a and a') on day 6 of culture, 
both cell populations  were lysed and the corresponding  cell ly- 
sates  were  immunoprecipitated  and  immunoblotted  with  anti- 
bodies against I~ID (a and b) or 131A (a' and b'). Arrows point to 
131D and  131A bands,  asterisks  in  C  indicate  immunoglobulin 
heavy chains. 
B, c-e). Upon the separation of myotubes and myoblasts 
in culture on day 6 after plating, we found that 131D was 
abundantly expressed in growing myotubes but was absent 
from postmitotic myoblasts (Fig. 7 C, a and b). In contrast, 
comparable levels of 131A expression in myoblasts and dif- 
ferentiating myotubes were found at this timepoint of myo- 
differentiation (Fig. 7 C, a'b'). 
By immunofluorescence, we also did not see any [31D in 
C2C12  myoblasts  except  for  some  distinct  perinuclear 
staining. This most likely corresponded to [31D accumula- 
tion in the Golgi apparatus (Fig. 8 A, arrows).  As cell fu- 
sion occurred in culture, early myotubes having 2-4 nuclei 
displayed  bright  regions  of  [31D immunostaining,  with 
clear  accumulation  of the  protein  at  focal adhesions  in 
myotube tips (Fig. 8 B, long arrow, arrowheads).  In larger, 
more mature myotubes, 131D appeared to accumulate at 
focal adhesions located throughout the entire ventral sur- 
face of the myotubes (Fig.  8  C, arrowheads).  A  fibrillar 
pattern of 131D on the dorsal surface of branching myo- 
tubes suggested codistribution with ECM fibrils (Fig. 8 D). 
Finally,  131D integrin  was  found  redistributed  to  cos- 
tameres of terminally differentiated contractile myotubes 
(Fig. 8 E, arrows). 
riD is Localized to Focal Adhesions 
in Transfected CHO Cells 
CHO cells were transfected with plasmids  encoding full- 
length human  131A and  131D isoforms of the [31 integrin 
subunit. As determined by FACS analysis of 131A integrin- 
and  131D integrin-transfected CHO cells, these cell lines 
expressed  comparable  amounts  of  transfected  integrin 
subunits on their surface (Table I). To analyze the intra- 
cellular localization of [31D in transfected CHO cells, we 
performed  double  immunofluorescent staining  of  these 
cells with TS2/16 mAb, which is specific for the extracellu- 
lar domain of human integrin 131 subunits, and polyclonal 
anti-talin antibodies. Immunofluorescent staining showed 
that 131D integrin is specifically accumulated at focal adhe- 
sions of CHO cells plated on fibronectin and is codistrib- 
uted with talin at these sites (Fig. 9, C and D). The pattern 
for  transfected  131D integrin  subunit  in  these  cells  was 
largely  indistinguishable  from  the  distribution  of  trans- 
fected 131A (Fig. 9, A  and B). Both 131A- and 131D-CHO 
transfectants  adhered  and  spread  similarly  on  surfaces 
coated with anti-human integrin TS2/16 mAb.  However, 
in this case both types of CHO transfectants remained less 
spread  than on a  fibronectin substrate,  and a  somewhat 
less distinct pattern of 131D and 131A localization in focal 
adhesions was observed (data not shown). 
Adhesion via fllD Integrin Causes Tyrosine 
Phosphorylation of  pp  l25  FAK 
We also used 131D-transfected CHO cells in adhesion ex- 
periments with TS2/16 mAb-coated culture flasks to deter- 
mine whether clustering 131D integrin leads to increased 
tyrosine phosphorylation of pp125  FAR. After plating of the 
131D-transfected CHO cells on the antibody substrate, we 
consistently observed an increase in tyrosine phosphoryla- 
tion of ~130-kD protein band corresponding to pp125  FAK 
(Fig. 10 B, arrow). This was detected as early as 15 min af- 
ter  plating  of  131D-CHO  transfectants  on  TS2/16  mAb 
(Fig.  10 B, b). The level of tyrosine phosphorylation of 
pp125  FAR in 131D-CHO  cells significantly increased by 30 
min and reached a  plateau thereafter (Fig.  10 B, c-e). A 
similar time course of pp125  FAK tyrosine phosphorylation 
was observed with the  131A-CHO  transfectants adhering 
to  surfaces  coated  with  the  same  antibody,  except  a 
slightly higher level of pp125  FAK phosphorylation was de- 
tected in  131A-CHO cells (Fig.  10 A, a-d).  It should be 
noted  that  lower  levels  of  tyrosine  phosphorylation  of 
pp125  FAR in 131D-CHO  cells at early timepoints of adhe- 
sion corresponded to a slower and less efficient spreading 
of 131D-CHO transfectants compared with the 131A-CHO 
counterparts (data not shown). 
fl  lD Integrin-Mediated Adhesion Leads 
to Activation of MAP Kinases 
Activation of MAP kinases  upon adhesion of [31A- and 
131D-CHO  transfectants  on TS2/16  mAb  was  examined 
first by mobility shift assay as described previously (Chen 
et al.,  1994; Zhu and Assoian, 1995).  Plating of the 131D- 
CHO transfectants on anti-integrin antibody caused a dis- 
tinct electrophoretic mobility shift of both the 42- and 44-kD 
MAP  kinase  bands  (Fig.  11  B, a  and  b,  arrows,  arrow- 
heads). The observed activation of MAP kinase was tran- 
sient, peaking at 30 min and had dropped by ~90 min after 
plating (Fig. 11 B, c and d). As detected by mobility shift 
kinase assay, the observed pattern of MAP kinase activa- 
tion in the case of 131D-mediated adhesion looked identi- 
The Journal of Cell Biology, Volume 132, 1996  220 Figure8.  Localization of 131D integrin isoform in differerentiating  cultured C2C12 myocytes. C2C12 myocytes were taken on day 3 (A), 
day 5 (B), day 7 (C), day 9 (D) and day 11 (E) of culture and stained with antibody specific for [31D integrin isoform. Arrows in A mark 
I31D localization in Golgi apparatus of growth-arrested myoblasts. Long arrow in B points to accumulation  of IMD isoform in early myo- 
tubes. Arrowheads in B and C indicate localization of 131D at myotube's focal adhesions. Small arrows in E mark presence of [31D inte- 
grin at costameres of differentiated contractile  myotubes. Bar, 10 ixm. 
cal to that seen for 131A-CHO transfectants (Fig. 11 A, ar- 
rows, arrowheads). 
To study adhesion-dependent activation of MAP kinase 
in  131D-CHO and [31A-CHO cells in more detail, we im- 
munoprecipitated MAP kinases and examined their enzy- 
matic activity by immune complex kinase assay using MBP 
as an exogenous substrate (Fig.  11,  C  and D). Again, we 
demonstrated that MAP kinases underwent transient acti- 
vation in CHO cells adhered via the [31D integrin isoform. 
The overall level and time course of adhesion-dependent 
MAP  kinase  activation  in  131D-CHO  transfectants  were 
largely  indistinguishable  from  those  observed  for  131A- 
CHO cells. 
Discussion 
Identification of the fllD Isoform and its Comparison 
with Other fll lntegrin Cytoplasmic Domain Variants 
It is commonly accepted that all adhesion-dependent cell 
types  express  one  or  more  131  integrin  heterodimers 
(Hynes, 1992).  Of the three previously identified cytoplas- 
mic domain variants of 131 integrin, two (131B and 131C) are 
minor isoforms (Languino and Ruoslahti,  1992; Balzac et 
al., 1993), leading to the idea that 131A is the predominant 
variant in most cells.  It was surprising,  therefore, that in 
our  preliminary  experiments  an  anti-peptide  antibody 
against  the  131A cytoplasmic domain failed  to  recognize 
the  antigen  in  either  adult  skeletal  or  cardiac  muscles, 
even though antibodies to the extracellular domain of 131 
Table I. Expression Level of the Human fllA and fllD Integrin 
Subunits in CHO Cells 
Cell type  % positive cells  Mean fluorescence intensity 
CHO-[31A  98.6  330 
CHO- 131D  95.4  250 
CHO  7.0  81 
CHO cells transfected with full-length human I31D or [31A cDNA and control un- 
transfected  CHO cells were reacted with saturating amounts of mAb BV7 specific for 
human 131 integrin subunit,  followed by fluorescein-labeled anti-mouse IgG and cell 
populations were analyzed by FACS. 
Belkin et al. fllD Integrin Displaces fllA in Muscle Cells  221 Figure 9.  Localization of [MD integrin isoform at focal adhesions of transfected CHO cells. 131A- (A and B) and 131D- (C and D) trans- 
fected CHO cells were plated on fibronectin substrate for 3 h and then double-stained with mAb TS2/16 specific for human 131 integrin 
subunit (A and C) and polyclonal antibody against talin (B and D). Bar, 50 ~m. 
integrin  had  been  reported  to  stain  the  sarcolemma 
brightly  (Bozyczko et  al.,  1989;  Swasdison  and  Mayne, 
1989). This observation has led us to this identification of a 
fourth cytoplasmic domain variant, [31D, which is specifi- 
cally expressed in muscle cells. This variant arises through 
differential splicing of [31 integrin pre-mRNA. Analysis of 
the  exon-intron  organization  of the  human  [31  integrin 
gene shows that the novel amino acid sequence of [MD is 
encoded by a  single additional exon D, located between 
exons 6 and 7 and upstream from exon C which encodes 
part of the  [31C cytoplasmic domain variant (N. I. Zhid- 
kova et al., 1995). Recently, similar data were obtained for 
mouse [31 integrin gene and [31D isoform (A. van der Flier 
et al., 1995). 
Comparing the four known cytoplasmic domain variants 
of the [31 integrin subunit (Fig. 1C) indicates that [31D is 
closest to the widely distributed [31A. In contrast, [31B and 
[MC are distinct and in the alternatively spliced regions of 
the cytoplasmic domain they show no homology with [31A 
(Tamkun et al., 1986; Argraves et al., 1987; Altruda et al., 
1990; Languino and Ruoslahti, 1992).  Of the 24 amino ac- 
ids encoded by the newly identified exon D, 13 are unique, 
whereas 11 are conserved between [31D and  [MA. Nota- 
bly, both NPXY  motifs  (780-783  and  792-795)  are  con- 
served between these two cytoplasmic domain variants. 
B1D Integrin Is the Predominant fll Integrin 
Isoform Expressed in Striated Muscles and Is Localized 
at Various Adherens-Type Junctions 
Analysis of the tissue distribution of the novel 131D inte- 
grin isoform showed that on the protein level its expres- 
sion is strictly limited to skeletal and cardiac muscle tis- 
sues. During myodifferentiation of C2C12 myocytes, [31A 
becomes progressively replaced by  131D. Moreover, the 
expression and localization of [31D and [31A in adult skele- 
tal and cardiac muscle tissues demonstrate that [MD dis- 
places the common 131A isoform in terminally differenti- 
ated  muscle  cells.  Although  we  cannot  say that  mature 
striated muscle cells have no [31A, the level appears to be 
very low  and  possibly  negligible.  Differentiated muscle 
cells appear, therefore, to be one of the few adherent ver- 
tebrate cells that have little or no [31A integrin. [31C is not 
expressed in adult striated muscles (G. Tarone, personal 
communication), whereas [31B was only detected in trace 
amounts in muscle tissues (Balzac et al.,  1993).  Together 
these results suggest that [31D is the predominant [31 inte- 
grin variant in striated muscles. 
Immunolocalization of [31D integrin in muscle cells re- 
vealed its presence in  all those junctional structures, in- 
cluding myotendinous junctions and neuromuscular junc- 
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rosine phosphorylation of pp125  FAK. 131A- (A) and  131D-trans- 
fected CHO cells (B) were either kept in suspension (a) or plated 
on TS2/16-covered tissue culture flasks for 15 rain (b), 30 min (c), 
60 min (d), or 150 min (e), pp125  PAK was immunoprecipitated us- 
ing  rabbit antiserum 5158, immunoprecipitates were run  on  a 
10% gel, proteins were transferred to the membrane and blots 
were probed using P¥20 anti-phosphotyrosine  mAb, followed by 
goat anti-mouse IgG, conjugated with peroxidase.  Arrows point 
to  pp125  FAK  bands.  Asterisks  indicate  immunoglobulin  heavy 
chains. 
Figure 11.  Cell adhesion  mediated by 131D integrin causes tran- 
sient activation  of MAP kinases. (A and B) Mobility shift assay 
for 131D- and 131A-mediated MAP kinase activation.  131A- (A) 
and 131D-transfected CHO cells (B) were either kept in suspen- 
sion (a) or plated on TS2/16-covered tissue culture  flasks for 30 
min (b), 90 rain (c) or 200 rain (d). Cell lysates were run on a 15% 
gel, proteins were transferred to the membrane and blots were 
probed with polyclonal antibody sc-94 against MAP kinases. Po- 
sitions of MAPK1  at 44 kD and MAPK2 at 42 kD are indicated 
by arrows.  Small  arrowheads  point  to  the  bands  of activated 
MAP kinases. (C and D) Immune complex kinase assay for 131D- 
and 131A-mediated MAP kinase activation.  131A- (C) and IMD- 
transfected CHO cells (D) were either kept in suspension  (a) or 
plated on TS2/16 mAb for 15 min (b), 30 min (c), 45 min (d) or 
150 min (e). MAP kinases were immunoprecipitated using sc-93 
polyclonal  antibody and immune complex kinase  reaction was 
performed with  the exogenous  substrate MBP,  as described  in 
Materials and Methods. Shown are phosphorylated MBP bands. 
tions of skeletal muscle and  costameres of both skeletal 
and cardiac muscle, that were previously described to con- 
tain the 131 integrin subunit (Bozyczko et al., 1989; Swasdi- 
son and Mayne, 1989).  Since we were unable to detect any 
131A isoform in  terminally differentiated muscle cells by 
immunostaining,  we  conclude  that  all  these  cell-matrix 
junctions contain only the  131D integrin variant. Here we 
also report localization of the 131D integrin isoform at in- 
tercalated discs, major cell-cell contact structures of cardio- 
myocytes. To our knowledge, this is the first demonstra- 
tion of 131 integrins in intercalated discs. It will be interesting 
to identify the extracellular ligand for 131D-containing in- 
tegrins at these sites. 
Analysis of the association of 131D integrin with et sub- 
units in vivo showed that among the et subunits analyzed in 
our  experiments,  a7B  is  the  only ot  subunit  complexed 
with 131D in cardiac muscle, whereas both et7A and et7B 
variants interact with 131D in skeletal muscle. Cytoplasmic 
domain structure does not contribute to the specificity of 
ct/~ subunit  association (Hemler et al.,  1994), but the re- 
stricted  tissue  expression  for both  131D and  et7  integrin 
subunits  and their colocalization in skeletal muscle fibers 
are striking (Song et al., 1992; Bao et al., 1993).  a7A131D 
and a7B131D appear to be the major integrin receptors in- 
volved in cytoskeletal-matrix interactions of differentiated 
striated muscles. 
Possible Functions of the [31D Integrin 
Isoform in Muscle Cells 
When 131D was expressed in CHO cells, it concentrated in 
focal  adhesions.  This  distinguishes  it  from the  131B iso- 
form, which neither  targets to focal adhesions nor is de- 
tected in adherens-type junctions (Balzac et al., 1993). The 
recruitment  of 131D to focal adhesions is consistent  with 
the similarity of its cytoplasmic domain to that of 131A and 
suggests that 131D may interact with some of the same cy- 
toskeletal proteins as  131A. Together, these  observations 
reflect constraints for the overall structure of the 131 inte- 
grin cytoplasmic domain with regard to its interaction with 
the actin cytoskeleton (Marcantonio et al., 1990; LaFlamme 
et al., 1992, 1994; Reszka et al., 1992; Pasqualini and Hem- 
ler, 1994; Lewis and Schwartz, 1995). Integrins of the 131A 
subfamily have been shown not only to have a  structural 
role linking the cytoskeleton to the ECM, but also to be in- 
volved in signaling. Transfection of human 131D into CHO 
cells enabled us to ask whether this integrin is also capable 
of signaling.  Clustering  of 131D integrins  in  these  trans- 
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pp125  FAK. The response was similar to the tyrosine phos- 
phorylation of pp125  FAK generated as a result of clustering 
transfected  [31A, but  less  effective, presumably  due  to 
slower spreading of 131D-CHO transfectants on anti-[31 in- 
tegrin antibody, pp125  FAK has been identified at myoten- 
dinous junctions (Baker et al., 1994). Although the func- 
tion of pp125 FAK at these sites has not been determined, it 
seems likely that it is associated with [31D. The interaction 
of [31A integrins with ECM also activates the MAP kinase 
pathway, possibly as a downstream consequence of pp125 FAK 
activation (Chen et al.,  1994; Schlaepfer et al.,  1994; Zhu 
and  Assoian,  1995).  Again,  using  the  transfected  CHO 
cells,  we  have  shown  that  131D is  capable  of activating 
MAP kinases and the overall level and time course of this 
activation were similar for [31D and  [31A isoforms. The 
relevance of this  pathway,  however,  to  mature  skeletal 
muscle cells is uncertain, since these cells are withdrawn ir- 
reversibly from the cell cycle after myoblast fusion. Also, 
it should be mentioned, that even though the  131D- and 
[31A-mediated response looked similar with the high con- 
centration of aggregating antibody, used in these experi- 
ments, at lower concentrations of the same antibody, we 
observed much slower spreading of the [31D-CHO trans- 
fectants compared with the 131A-CHO  cells. This was ac- 
companied  by  decreased  tyrosine  phosphorylation  of 
pp125 FAK and delayed activation of MAP kinases in the 
case of [31D transfectants (data not shown). These obser- 
vations suggest that under conditions of nonmuscle envi- 
ronment, 131D may be less effective than 131A with regard 
to integrin-mediated signaling.  In muscle cells, however, 
one cannot exclude that 131D transmits different or sub- 
stantially modified signals compared with [31A. This might 
occur if muscle-specific signaling molecules are expressed 
that interact with 131D. 
Expression of the 131 integrin subunit, as well as the oc- 
cupation of 131-containing  integrin heterodimers is neces- 
sary for myodifferentiation and  the  formation of sarco- 
meric cytoarchitecture (Menko and Boettiger, 1987; Volk 
et al.,  1990).  Since the majority of [31 integrins are repre- 
sented by the 131D isoform in differentiated skeletal mus- 
cle, the function of [31 integrin during myodifferentiation 
should be mostly attributed to this novel cytoplasmic do- 
main isoform. A major function for integrins is to transmit 
tension  generated  by  the  actin  cytoskeleton across  the 
plasma membrane to the ECM. The forces generated by 
striated  muscles  are  considerably greater  than  those  of 
most other cells. It is easy to envisage how there may be a 
need for an integrin with a unique cytoplasmic domain to 
transmit this higher tension across the muscle membrane. 
The restricted distribution of 131D and its enrichment at 
myotendinous junctions and costameres, which represent 
major force transmission sites in skeletal muscle, are con- 
sistent  with  such  a  function.  Like  131D, several  compo- 
nents  of the  peripheral membrane  cytoskeleton are  ex- 
pressed only in muscle tissues. These include dystrophin, 
syntrophin and aciculin (Froehner et al., 1987; Hoffman et 
al., 1987; Watkins et al., 1988; Ervasti and Campbell, 1991, 
1993; Sealock et al., 1991; Porter et al., 1992; Straub et al., 
1992;  Adams  et al.,  1993;  Yang et al.,  1994;  Belkin and 
Burridge, 1994, 1995). One mode of attachment of dystro- 
phin to the sarcolemma involves a non-integrin ECM re- 
ceptor dystroglycan (Ervasti  and  Campbell,  1991,  1993; 
Ibraghimov-Beskrovnaya  et  al.,  1992).  However,  addi- 
tional linkages may also be involved and it will be impor- 
tant  to  explore  whether  the  131D cytoplasmic  domain 
binds  to dystrophin or other unique  components of the 
subsarcolemmal cytoskeleton. With most integrins, the in- 
teractions with ECM ligands, as well as with cytoskeletal 
proteins, involves relatively low affinities (Horwitz et al., 
1986; Otey et al., 1990; Hynes, 1992). Presumably these are 
sufficient for the necessary anchorage and traction of most 
cells, without precluding the remodeling that must occur 
during cell migration. With striated muscles the require- 
ments are different. Mature muscle cells do not migrate 
and, as mentioned above, the tensile forces that have to be 
transmitted are high. Consequently, high affinity interac- 
tions involving integrins may be both tolerated and desir- 
able.  One  possibility is  that  the  unique  cytoplasmic se- 
quence of the [31D integrin subunit increases the affinity 
of 131D integrin heterodimers for cytoskeletal or both cy- 
toskeletal and extracellular ligands. We hope to test this 
possibility in our future work. 
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